Inventor · disambiguated record
Sven Jacobson
Also filed as: JACOBSON SVEN · JACOBSON SVEN M · JACOBSON SVEN MARTIN
42 granted patents·52 pending applications·229 citations·filing 2006–2025
98Inventor score
Files withWOOLSEY PHARMACEUTICALS INC28BIOGEN CHESAPEAKE LLC18REMEDY PHARMACEUTICALS INC15CRITICAL CARE DIAGNOSTICS INC13JACOBSON SVEN4
Top patents by PatentIndex Score
94 records- 0198US8617825B2Predicting mortality and detecting severe diseaseSNIDER JAMES V·Filed 2011·Granted Dec 31, 2013·35 cites·18 claims
- 0298US7998683B2Predicting mortality and detecting severe diseaseCRITICAL CARE DIAGNOSTICS INC·Filed 2007·Granted Aug 16, 2011·46 cites·18 claims
- 0397US12251389B1Methods of treating ischemic stroke at risk for cerebral or cerebellar edemaREMEDY PHARMACEUTICALS INC·Filed 2024·Granted Mar 18, 2025·6 cites·30 claims
- 0496US9057733B2Predicting mortality and detecting severe diseaseCRITICAL CARE DIAGNOSTICS INC·Filed 2013·Granted Jun 16, 2015·15 cites·23 claims
- 0595US12251388B1Methods of treating ischemic stroke at risk for cerebral or cerebellar edemaREMEDY PHARMACEUTICALS INC·Filed 2024·Granted Mar 18, 2025·4 cites·14 claims
- 0695US11311553B1Methods of treating 4-repeat tauopathiesWOOLSEY PHARMACEUTICALS INC·Filed 2021·Granted Apr 26, 2022·5 cites·18 claims
- 0794US11771704B1Methods of using rho kinase inhibitors to treat alzheimer's diseaseWOOLSEY PHARMACEUTICALS INC·Filed 2023·Granted Oct 3, 2023·1 cites·13 claims
- 0894US11642352B2Methods of treating wandering in Lewy dody dementiaWOOLSEY PHARMACEUTICALS INC·Filed 2021·Granted May 9, 2023·3 cites·12 claims
- 0994US9568481B2Methods of identifying a subject as having heart failureSNIDER JAMES V·Filed 2011·Granted Feb 14, 2017·9 cites·24 claims
- 1094US8277845B2Formulations and methods for lyophilization and lyophilates provided therebyJACOBSON SVEN·Filed 2008·Granted Oct 2, 2012·27 cites·9 claims
- 1192US8946293B2Methods of intravenous administration of glyburide and other drugsJACOBSON SVEN MARTIN·Filed 2011·Granted Feb 3, 2015·18 cites·22 claims
- 1291US11865119B2Methods of treating agitation and other dementia-associated behavioral symptomsWOOLSEY PHARMACEUTICALS INC·Filed 2023·Granted Jan 9, 2024·1 cites·27 claims
- 1391US10004703B2Treatment of alzheimer's disease using compounds that reduce the activity of non-selective CA++ activated ATP-sensitive cation channels regulated by SUR1 channelsBIOGEN CHESAPEAKE LLC·Filed 2013·Granted Jun 26, 2018·15 cites·11 claims
- 1490US10441556B2Composition containing glibenclamideBIOGEN CHESAPEAKE LLC·Filed 2018·Granted Oct 15, 2019·10 cites·11 claims
- 1589US10303844B2Multimarker risk stratificationCRITICAL CARE DIAGNOSTICS INC·Filed 2016·Granted May 28, 2019·6 cites·19 claims
- 1687US11666583B2Methods of treating cortical dementia associated wanderingWOOLSEY PHARMACEUTICALS INC·Filed 2021·Granted Jun 6, 2023·1 cites·15 claims
- 1787US10869835B2Formulations and methods for lyophilization and lyophilates provided therebyBIOGEN CHESAPEAKE LLC·Filed 2019·Granted Dec 22, 2020·1 cites·23 claims
- 1887US10052280B2Methods of intravenous administration of glyburideBIOGEN CHESAPEAKE LLC·Filed 2017·Granted Aug 21, 2018·3 cites·17 claims
- 1987US8858997B2Formulations and methods for lyophilization and lyophilates provided therebyJACOBSON SVEN·Filed 2012·Granted Oct 14, 2014·7 cites·18 claims
- 2086US10426729B2Formulations and methods for lyophilization and lyophilates provided therebyBIOGEN CHESAPEAKE LLC·Filed 2018·Granted Oct 1, 2019·3 cites·18 claims
- 2185US12226521B2Methods of intravenous administration of glyburideREMEDY PHARMACEUTICALS INC·Filed 2023·Granted Feb 18, 2025·0 cites·20 claims
- 2285US2025017880A1Methods of treating injuries or conditions related to cns edemaREMEDY PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2384US10117834B2Formulations and methods for lyophilization and lyophilates provided therebyBIOGEN CHESAPEAKE LLC·Filed 2014·Granted Nov 6, 2018·4 cites·17 claims
- 2484US10067146B2Predicting mortality and detecting severe diseaseCRITICAL CARE DIAGNOSTICS INC·Filed 2017·Granted Sep 4, 2018·1 cites·20 claims
- 2584US9254259B2Methods of intravenous administration of glyburideREMEDY PHARMACEUTICALS INC·Filed 2014·Granted Feb 9, 2016·3 cites·63 claims
- 2683US10758503B2Composition containing glibenclamideBIOGEN CHESAPEAKE LLC·Filed 2019·Granted Sep 1, 2020·1 cites·20 claims
- 2783US2025032441A1Method of Treating AscitesMARTIN PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2883US2025345347A1Methods of treating ischemic stroke at risk for cerebral or cerebellar edemaREMEDY PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 2982US12290522B2Method of treating amyotrophic lateral sclerosisWOOLSEY PHARMACEUTICALS INC·Filed 2023·Granted May 6, 2025·0 cites·22 claims
- 3082US2024216309A1Methods of treating injuries or conditions related to cns edemaREMEDY PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 3179US2025339448A1Methods of treating ischemic stroke at risk for cerebral or cerebellar edemaREMEDY PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 3279US2024100064A1Methods of treating neurodevelopmental disordersWOOLSEY PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 3378US12337006B1Methods of treating ischemic stroke at risk for cerebral or cerebellar edemaREMEDY PHARMACEUTICALS INC·Filed 2025·Granted Jun 24, 2025·0 cites·30 claims
- 3478US10741290B2Multimarker risk stratificationCRITICAL CARE DIAGNOSTICS INC·Filed 2019·Granted Aug 11, 2020·1 cites·15 claims
- 3577US11951085B2Methods of treating injuries or conditions related to CNS edemaBIOGEN CHESAPEAKE LLC·Filed 2021·Granted Apr 9, 2024·0 cites·20 claims
- 3677US11559481B2Methods of intravenous administration of glyburideBIOGEN CHESAPEAKE LLC·Filed 2020·Granted Jan 24, 2023·0 cites·22 claims
- 3777US10688111B2Liquid formulations of compounds active at sulfonylurea receptorsBIOGEN CHESAPEAKE LLC·Filed 2016·Granted Jun 23, 2020·2 cites·24 claims
- 3876US12268661B2Methods of treating ascitesMARTIN PHARMACEUTICALS INC·Filed 2021·Granted Apr 8, 2025·0 cites·12 claims
- 3976US11779588B2Method of treating amyotrophic lateral sclerosisWOOLSEY PHARMACEUTICALS INC·Filed 2021·Granted Oct 10, 2023·0 cites·16 claims
- 4076US2025221924A1Methods of intravenous administration of glyburideREMEDY PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 4175US2025268911A1Methods of Using RHO Kinase Inhibitors to Treat Alzheimer's DiseaseWOOLSEY PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 4274US2021255200A1Predicting mortality and detecting severe diseaseCRITICAL CARE DIAGNOSTICS INC·Filed 2021·Application pending·0 cites
- 4374US2021244669A1Formulations and methods for lyophilization and lyophilates provided therebyBIOGEN CHESAPEAKE LLC·Filed 2020·Application pending·0 cites
- 4473US12329761B2Methods of using rho kinase inhibitors to treat alzheimer's diseaseWOOLSEY PHARMACEUTICALS INC·Filed 2021·Granted Jun 17, 2025·0 cites·12 claims
- 4573US10786445B2Methods of intravenous administration of glyburideBIOGEN CHESAPEAKE LLC·Filed 2019·Granted Sep 29, 2020·0 cites·20 claims
- 4673US2025228868A1Method of treating amyotrophic lateral sclerosisWOOLSEY PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 4772US12274687B2Methods for treating ascitesMARTIN PHARMACEUTICALS INC·Filed 2022·Granted Apr 15, 2025·0 cites·17 claims
- 4872US2023248739A1Methods of treating cortical dementia associated wanderingWOOLSEY PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 4972US2023226073A1Methods of treating proteinopathy associated wanderingWOOLSEY PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 5071US2021251943A1Method of Treating AscitesJACOBSON SVEN·Filed 2021·Application pending·0 cites
Showing the top 50 of 94 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Sven Jacobson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →